September
02, 2010
06:45
PM CET
search
Disclaimer
PRIVACY POLICY
Imprint
RSS
©2010
EVOTEC
Evotec - Research never stops
Home
Contact Us
Archive
Downloads
Loading...
About us
History
Management
Supervisory Board
Honorary Chairman
Scientific Advisory Board
Careers
Products & Services
Integrated Services
Assay Development & Screening
Fragment-based Drug Discovery
Medicinal Chemistry & Early Development
ADMET & Zebrafish Screening
Pipeline
Clinical
Preclinical
Partners
Our Partners
Our Technology Partners
Business Development Events
Scientific Publications
Investors
Press Releases
Events / Annual General Meeting
Finance
Analysts
Stock Information
Corporate Governance
Pipeline
Clinical
Preclinical
EVT 501 - H3 Antagonists
Insulin Sensitizer - Targeting Insulin Resistance
P2X3 and P2X2/3 Antagonists
B1 Antagonists
Beta Cell Regeneration Factor
Kv1.3 inhibitors
Preclinical Overview
Preclinical
EVT 501 - H3 Antagonists
- read more
Insulin Sensitizer - Targeting Insulin Resistance
- read more
P2X3 and P2X2/3 Antagonists
- read more
B1 Antagonists
- read more
Beta Cell Regeneration Factor
- read more
Kv1.3 inhibitors
- read more
